Madopar 25/100 25 mg / 100 mg Noruega - noruego - Statens legemiddelverk

madopar 25/100 25 mg / 100 mg

roche norge as - benserazidhydroklorid / levodopa - kapsel, hard - 25 mg / 100 mg

Madopar Depot 25/100 25 mg / 100 mg Noruega - noruego - Statens legemiddelverk

madopar depot 25/100 25 mg / 100 mg

roche norge as - benserazidhydroklorid / levodopa - depotkapsel, hard - 25 mg / 100 mg

Madopar Solubile 12,5/50 12.5 mg / 50 mg Noruega - noruego - Statens legemiddelverk

madopar solubile 12,5/50 12.5 mg / 50 mg

roche norge as - benserazidhydroklorid / levodopa - oppløselig tablett - 12.5 mg / 50 mg

Alpivab Unión Europea - noruego - EMA (European Medicines Agency)

alpivab

biocryst - peramivir - influensa, human - antivirale midler til systemisk bruk - alpivab er angitt for behandling av ukomplisert influensa i voksne og barn fra en alder av 2 år.

Quofenix Unión Europea - noruego - EMA (European Medicines Agency)

quofenix

a. menarini industrie farmaceutiche riunite s.r.l. - delafloxacin meglumine - fellesskapsmessige infeksjoner - antibakterielle midler for systemisk bruk, - quofenix is indicated for the treatment of the following infections in adults:acute bacterial skin and skin structure infections (absssi),community-acquired pneumonia (cap), when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the initial treatment of these infections (see sections 4. 4 og 5. det bør vurderes å offisielle retningslinjer for riktig bruk av antibakterielle midler.

Xenleta Unión Europea - noruego - EMA (European Medicines Agency)

xenleta

nabriva therapeutics ireland dac - lefamulin acetate - pneumonia, bacterial; community-acquired infections - antibakterielle midler for systemisk bruk, - xenleta is indicated for the treatment of community-acquired pneumonia (cap) in adults when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of cap or when these have failed. det bør vurderes å offisielle retningslinjer for riktig bruk av antibakterielle midler.

Bylvay Unión Europea - noruego - EMA (European Medicines Agency)

bylvay

albireo - odevixibat - cholestasis, intrahepatic - galle- og leverterapi - bylvay is indicated for the treatment of progressive familial intrahepatic cholestasis (pfic) in patients aged 6 months or older (see sections 4. 4 og 5.

Scemblix Unión Europea - noruego - EMA (European Medicines Agency)

scemblix

novartis europharm limited - asciminib hydrochloride - leukemi, myelogen, kronisk, bcr-abl positiv - antineoplastiske midler - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.

Cholib Unión Europea - noruego - EMA (European Medicines Agency)

cholib

viatris healthcare limited - fenofibrate, simvastatin - dyslipidemiene - lipid modifiserende midler - cholib angis som tilleggsbehandling behandling til kosthold og mosjon i høy kardiovaskulær risiko voksne pasienter med blandet dyslipidaemia å redusere triglyserider og øke hdl c nivåer når ldl c nivåer er tilstrekkelig kontrollert med den tilsvarende dosen simvastatin monoterapi.

Olanzapine Accord 2.5 mg Noruega - noruego - Statens legemiddelverk

olanzapine accord 2.5 mg

accord healthcare b.v. - olanzapin - tablett, filmdrasjert - 2.5 mg